Evommune EVMN
NYSE EVMN
$7.03 -1.23 (-14.92%)
As of: Oct 1, 2026 · 2:15 PM EDT

Evommune (EVMN) Liabilities and Shareholders Equity (2024 - 2026)

Updated

Evommune's Liabilities and Shareholders Equity was $301.95 million in Q2 2026, down 6.4% from the prior quarter.

Analysis

Evommune (EVMN) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Evommune came in at $224.95 million, up 195.8% from FY2024.

  • In earlier years, Liabilities and Shareholders Equity was $76.06 million in FY2024.
  • Quarterly Liabilities and Shareholders Equity has moved between $76.06 million (Q4 2024) and $322.46 million (Q1 2026) over five years.
  • Per Business Quant data, EVMN's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $322.46 million (Q1 2026), $224.95 million (Q4 2025) and $84.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Evommune 299.69 Mn -337.83 Mn - 301.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 301.95 Mn
Mar 31, 2026 322.46 Mn
Dec 31, 2025 224.95 Mn
Sep 30, 2025 84.54 Mn
Dec 31, 2024 76.06 Mn
API Access

Evommune Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EVMN&period=max&api_key=YOUR_API_KEY